Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Coenen

Showing results (181-190 of 208) with videos related to

Pageof 21
Sort By:
Frontiers in Immunology|November 8, 2023
T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adultsBruno Salaun, Jonathan De Smedt, Charlotte Vernhes, et al.
The European Respiratory Journal|October 16, 2020
Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort studyKoos Korsten, Niels Adriaenssens, Samuel Coenen, et al.
The Journal of Antimicrobial Chemotherapy|June 30, 2016
Impact of amoxicillin therapy on resistance selection in patients with community-acquired lower respiratory tract infections: a randomized, placebo-controlled studySurbhi Malhotra-Kumar, Liesbet Van Heirstraeten, Samuel Coenen, et al.
Annals of Family Medicine|November 15, 2012
Airway obstruction and bronchodilator responsiveness in adults with acute coughSaskia van Vugt, Lidewij Broekhuizen, Nicolaas Zuithoff, et al.
Plos One|February 23, 2024
One Health surveillance of colistin-resistant Enterobacterales in Belgium and the Netherlands between 2017 and 2019Sien De Koster, Basil Britto Xavier, Christine Lammens, et al.
European Journal of Epidemiology|June 1, 2022
Transmission of SARS-CoV-2 within households: a remote prospective cohort study in European countriesJanneke D M Verberk, Marieke L A de Hoog, Ilse Westerhof, et al.
Vaccines|August 29, 2024
Follow-Up of SARS-CoV-2 Antibody Levels in Belgian Nursing Home Residents and Staff Two, Four and Six Months after Primary Course BNT162b2 VaccinationEline Meyers, Liselore De Rop, Fien Engels, et al.
Clinical Drug Investigation|July 22, 2021
Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC<sup>4</sup>E TrialXiao Li, Joke Bilcke, Alike W van der Velden, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European CountriesAkke Vellinga, Addiena Luke-Currier, Nathaly Garzón-Orjuela, et al.
The Lancet. Infectious Diseases|December 26, 2012
Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trialPaul Little, Beth Stuart, Michael Moore, et al.
Pageof 21

Showing results (181-190 of 208) with videos related to

Sort By:
Pageof 21
Frontiers in Immunology|November 8, 2023
T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adultsBruno Salaun, Jonathan De Smedt, Charlotte Vernhes, et al.
The European Respiratory Journal|October 16, 2020
Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort studyKoos Korsten, Niels Adriaenssens, Samuel Coenen, et al.
The Journal of Antimicrobial Chemotherapy|June 30, 2016
Impact of amoxicillin therapy on resistance selection in patients with community-acquired lower respiratory tract infections: a randomized, placebo-controlled studySurbhi Malhotra-Kumar, Liesbet Van Heirstraeten, Samuel Coenen, et al.
Annals of Family Medicine|November 15, 2012
Airway obstruction and bronchodilator responsiveness in adults with acute coughSaskia van Vugt, Lidewij Broekhuizen, Nicolaas Zuithoff, et al.
Plos One|February 23, 2024
One Health surveillance of colistin-resistant Enterobacterales in Belgium and the Netherlands between 2017 and 2019Sien De Koster, Basil Britto Xavier, Christine Lammens, et al.
European Journal of Epidemiology|June 1, 2022
Transmission of SARS-CoV-2 within households: a remote prospective cohort study in European countriesJanneke D M Verberk, Marieke L A de Hoog, Ilse Westerhof, et al.
Vaccines|August 29, 2024
Follow-Up of SARS-CoV-2 Antibody Levels in Belgian Nursing Home Residents and Staff Two, Four and Six Months after Primary Course BNT162b2 VaccinationEline Meyers, Liselore De Rop, Fien Engels, et al.
Clinical Drug Investigation|July 22, 2021
Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC<sup>4</sup>E TrialXiao Li, Joke Bilcke, Alike W van der Velden, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European CountriesAkke Vellinga, Addiena Luke-Currier, Nathaly Garzón-Orjuela, et al.
The Lancet. Infectious Diseases|December 26, 2012
Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trialPaul Little, Beth Stuart, Michael Moore, et al.
Pageof 21